Cart
sales@molnova.com
Home - Products - Metabolic Enzyme/Protease - FAAH - PDP-EA

PDP-EA

CAS No. 861891-72-7

PDP-EA( —— )

Catalog No. M27912 CAS No. 861891-72-7

PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 45 In Stock
2MG 28 In Stock
5MG 41 In Stock
10MG 69 In Stock
25MG 112 In Stock
50MG 166 In Stock
100MG 253 In Stock
200MG 365 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    PDP-EA
  • Note
    Research use only, not for human use.
  • Brief Description
    PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.
  • Description
    PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    FAAH
  • Recptor
    IGFBP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    861891-72-7
  • Formula Weight
    405.623
  • Molecular Formula
    C25H43NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (123.27 mM)
  • SMILES
    CCCCCCCCCCCCCCCc1cccc(OCC(=O)NCCO)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rinker TE, et al. Microparticle-mediated sequestration of cell-secreted proteins to modulate chondrocytic differentiation. Acta Biomater. 2017 Dec 30. pii: S1742-7061(17)30804-8.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • PF-3845

    PF-3845 is a potent, selective and irreversible FAAH inhibitor with Ki of 230 nM, showing negligible activity against FAAH2.

  • VU534

    VU534 is a NAPE-PLD agonist with an EC50 of 0.30 μM.VU534 is a dual inhibitor of FAAH and sEH, with an IC50 of 1.2 μM for sEH.VU534 is used in diseases related to cardiometabolism.

  • WWL 154

    WWL 154 is an serine hydrolase (SH) and fatty acid amide hydrolase FAAH-4 inhibitor.

Sign In Join Free